These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1672878)

  • 1. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis.
    Schata M; Jorde W; Richarz-Barthauer U
    J Allergy Clin Immunol; 1991 Apr; 87(4):873-8. PubMed ID: 1672878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of levocabastine nasal spray with sodium cromoglycate nasal spray in the treatment of seasonal allergic rhinitis.
    Palma-Carlos AG; Chieira C; Conde TA; Cordeiro JA
    Ann Allergy; 1991 Oct; 67(4):394-8. PubMed ID: 1683189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children.
    Vermeulen J; Mercer M
    Pediatr Allergy Immunol; 1994 Nov; 5(4):209-13. PubMed ID: 7894627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of levocabastine nasal spray for seasonal allergic rhinitis.
    Hampel FC; Martin BG; Dolen J; Travers S; Karcher K; Holton D
    Am J Rhinol; 1999; 13(1):55-62. PubMed ID: 10088031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical levocabastine is more effective than sodium cromoglycate for the prophylaxis and treatment of seasonal allergic conjunctivitis.
    Davies BH; Mullins J
    Allergy; 1993 Oct; 48(7):519-24. PubMed ID: 7902022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.
    Janssens MM
    Rhinol Suppl; 1992 Sep; 13():39-49. PubMed ID: 1358140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of levocabastine eye drops with sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis.
    Azevedo M; Castel-Branco MG; Oliveira JF; Ramos E; Delgado L; Almeida J
    Clin Exp Allergy; 1991 Nov; 21(6):689-94. PubMed ID: 1685691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levocabastine: an effective topical treatment of allergic rhinoconjunctivitis.
    Janssens MM; Vanden Bussche G
    Clin Exp Allergy; 1991 May; 21 Suppl 2():29-36. PubMed ID: 1680536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.
    Noble S; McTavish D
    Drugs; 1995 Dec; 50(6):1032-49. PubMed ID: 8612470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal levocabastine for the treatment of seasonal allergic rhinitis: a multicentre, double-blind, placebo-controlled trial.
    Dahl R; Pedersen B; Larsen B
    Rhinology; 1995 Sep; 33(3):121-5. PubMed ID: 8560160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis.
    Odelram H; Björkstén B; af Klercker T; Rimås M; Kjellman NI; Blychert LO
    Allergy; 1989 Aug; 44(6):432-6. PubMed ID: 2572181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of topical levocabastine compared with oral terfenadine.
    Bahmer FA; Ruprecht KW
    Ann Allergy; 1994 May; 72(5):429-34. PubMed ID: 7909999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of topical levocabastine and sodium cromoglycate in the treatment of pollen-provoked allergic conjunctivitis.
    Frostad AB; Olsen AK
    Clin Exp Allergy; 1993 May; 23(5):406-9. PubMed ID: 8101467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal levocabastine provides fast and effective protection from nasal allergen challenge.
    Bachert C; Wagenmann M; Vossen-Holzenkamp S
    Rhinology; 1996 Sep; 34(3):140-3. PubMed ID: 8938880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen.
    Kolly M; Pécoud A
    Br J Clin Pharmacol; 1986 Oct; 22(4):389-94. PubMed ID: 2876723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.
    Dechant KL; Goa KL
    Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of topical budesonide and levocabastine on nasal symptoms and plasma exudation responses in seasonal allergic rhinitis.
    Svensson C; Andersson M; Greiff L; Blychert LO; Persson CG
    Allergy; 1998 Apr; 53(4):367-74. PubMed ID: 9574878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical levocabastine compared with oral loratadine for the treatment of seasonal allergic rhinoconjunctivitis. Swedish GP Allergy Team.
    Allergy; 1994 Sep; 49(8):611-5. PubMed ID: 7653738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.